Preimplantation genetic testing (PGT) lets fertility specialists examine embryos for chromosomal and genetic conditions before transferring them into the uterus during in vitro fertilization (IVF). If you're navigating IVF or exploring options due to recurrent pregnancy loss, understanding how PGT works helps clarify what to expect during a cycle.
The primary goal of PGT is to identify healthy embryos with the correct chromosome count or without specific single-gene mutations. By filtering out embryos carrying structural abnormalities or monogenic disorders, patients can lower miscarriage rates and improve the likelihood of a successful pregnancy on the first transfer.
Understanding the Categories of Preimplantation Genetic Testing
Clinical protocols divide PGT into distinct categories based on what the laboratory evaluates. Each type serves a specific medical purpose depending on patient history, age, or known familial conditions.
- PGT-A (Aneuploidy): Screens embryos for an abnormal number of chromosomes, known as aneuploidy. Conditions like Down syndrome stem from extra or missing chromosomes. This screening helps clinics select euploid embryos with the correct set of 46 chromosomes.
- PGT-M (Monogenic/Single-Gene Disorders): Targets specific hereditary conditions caused by mutations in a single gene, such as cystic fibrosis, sickle cell anemia, or Huntington's disease. Families with a known history of genetic disorders use PGT-M to block transmission to future generations.
- PGT-SR (Structural Rearrangements): Identifies chromosomal structural shifts like translocations or inversions where pieces of chromosomes swap places. Parents carrying balanced translocations often face high miscarriage rates, making PGT-SR critical for finding balanced embryos.
The Step-by-Step Clinical Process
Undergoing PGT requires coordination between your fertility clinic, the embryology lab, and a specialized genetic testing laboratory. The workflow follows several precise phases during an IVF cycle. Further information regarding the matter are detailed by Associated Press.
- Ovarian Stimulation and Retrieval: The patient undergoes hormone injections to stimulate the ovaries, followed by an outpatient procedure to retrieve mature eggs.
- Fertilization via ICSI: Embryologists fertilize the eggs in the lab using intracytoplasmic sperm injection (ICSI) to ensure clean DNA samples without stray sperm contamination.
- Embryo Culture to Blastocyst Stage: Fertilized eggs develop in incubators for five to six days until they reach the blastocyst stage, consisting of roughly 100 to 150 cells.
- Trophectoderm Biopsy: Specialists remove five to ten cells from the trophectoderm—the part of the blastocyst that develops into the placenta—leaving the inner cell mass untouched.
- Genetic Analysis: The biopsy sample undergoes whole genome amplification and sequencing at a molecular genetics laboratory while the embryos are cryopreserved (frozen).
- Embryo Transfer: Armed with test results, the physician thaws a verified euploid or unaffected embryo for transfer into the prepared uterine lining.
Common Misconceptions and Procedural Realities
Patients often encounter conflicting information regarding what genetic screening can and cannot accomplish. Recognizing these realities prevents misplaced expectations during fertility treatment.
Many assume that testing guarantees a live birth. While screening removes chromosomal hurdles, implantation depends heavily on uterine health, hormonal balance, and embryo quality. Additionally, embryos can exhibit mosaicism—mixtures of normal and abnormal cells within the same sample—which requires careful genetic counseling to interpret.
Another common question involves embryo damage. Because biopsies draw cells exclusively from the outer trophectoderm layer rather than the inner cell mass, modern techniques maintain high safety margins for embryo viability.
Frequently Asked Questions
Who is a candidate for PGT-A?
Clinicians often recommend PGT-A for patients experiencing advanced maternal age, repeated implantation failure after multiple normal transfers, or a history of recurrent miscarriages.
Can PGT detect all birth defects?
No. PGT screens for specific targeted genetic mutations, structural rearrangements, or whole chromosome counts. It doesn't test for environmental factors, multi-factorial conditions, or developmental issues that arise later during pregnancy.
What happens to abnormal embryos?
Embryos diagnosed with severe chromosomal anomalies or targeted genetic conditions are typically discarded with patient consent, or donated for approved scientific research depending on clinic protocols and local regulations.
How long do PGT results take?
Turnaround times vary by laboratory, but results usually return within one to three weeks. During this period, embryos remain safely cryopreserved in liquid nitrogen storage.
